/Companies

Intero Biosystems

4 known investors

Find your way into Intero Biosystems

Sign up to see every warm intro you have to Intero Biosystems

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Intero Biosystems team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.

Founders & leadership

CCCharlie Childs
Charlie ChildsCEOCharlie Childs is Head of AI Strategy at Intero Biosystems, which develops stem-cell-derived intestinal organoids for preclinical drug testing and discovery applications.30 Under 30 2026
MEMadeline Eiken
Madeline EikenCTO/COO30 Under 30 2026
JSJason Spence
Jason SpenceCSO

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Intero Biosystems do?
Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
Who founded Intero Biosystems?
Intero Biosystems was founded by Charlie Childs, Madeline Eiken, Jason Spence.
Who are Intero Biosystems's investors?
Intero Biosystems's investors include Colorado BioScience Association, GOOSE Capital, Houston Angel Network, Michigan Rise.